Rhön-Klinikum Aktiengesellschaft (RHK) Given a €26.30 Price Target at Warburg Research

Warburg Research set a €26.30 ($30.58) price target on Rhön-Klinikum Aktiengesellschaft (ETR:RHK) in a research note published on Monday morning. The brokerage currently has a neutral rating on the stock.

Other equities research analysts have also issued reports about the company. DZ Bank AG reaffirmed a sell rating on shares of Rhön-Klinikum Aktiengesellschaft in a research report on Tuesday, August 29th. Deutsche Bank AG set a €21.00 ($24.42) target price on Rhön-Klinikum Aktiengesellschaft and gave the stock a neutral rating in a research report on Wednesday, July 26th. Commerzbank Ag set a €25.00 ($29.07) target price on Rhön-Klinikum Aktiengesellschaft and gave the stock a neutral rating in a research report on Tuesday, July 25th. Credit Suisse Group set a €24.40 ($28.37) target price on Rhön-Klinikum Aktiengesellschaft and gave the stock a sell rating in a research report on Friday, August 4th. Finally, Berenberg Bank set a €26.00 ($30.23) target price on Rhön-Klinikum Aktiengesellschaft and gave the stock a neutral rating in a research report on Tuesday, August 1st. Four analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. Rhön-Klinikum Aktiengesellschaft has an average rating of Hold and a consensus price target of €25.05 ($29.13).

Rhön-Klinikum Aktiengesellschaft (RHK) traded down €0.18 ($0.21) on Monday, hitting €30.02 ($34.91). The stock had a trading volume of 85,284 shares, compared to its average volume of 71,494. Rhön-Klinikum Aktiengesellschaft has a 12 month low of €22.66 ($26.35) and a 12 month high of €30.65 ($35.64).

TRADEMARK VIOLATION WARNING: This piece was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.chaffeybreeze.com/2017/11/14/rhon-klinikum-aktiengesellschaft-rhk-given-a-26-30-price-target-at-warburg-research.html.

Rhön-Klinikum Aktiengesellschaft Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhön-Klinikum Aktiengesellschaft (ETR:RHK)

Receive News & Ratings for Rhön-Klinikum Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhön-Klinikum Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply